Marvell’s $115B AI Bet on Lumentum: November 2026 Stock Outlook
Marvell Technology agreed on November 2 to buy Lumentum Holdings in an all-stock deal with an announced enterprise value of $115 billion, bringing together two suppliers of the technology that connects AI data centers. Investors responded by selling both stocks. Marvell closed down 12.72%, while Lumentum fell 18.59%.
The terms help explain why an acquisition announced at a premium could still leave the target’s shareholders facing a loss. Lumentum holders would receive 4.5 Marvell shares for each share they own. As Marvell’s stock fell, so did the value of that offer.
At Monday’s close, those shares were worth about $771.35, well below the roughly $1,132 reference value in the announcement. The companies calculated that earlier figure using October 28 prices, before takeover speculation began. Closing is expected in the first half of 2028, subject to shareholder votes, regulatory approvals and other conditions.
Prices and valuation figures in this article use the November 2, 2026 regular-session close.
This article is educational, informational research—not financial advice.
We strive to keep data accurate, but unavoidable errors or omissions may occur. Verify important information with primary sources.
Why Marvell wants Lumentum
Marvell designs semiconductors for data infrastructure, including custom computing chips and high-speed connections. Lumentum makes optical components and systems, including lasers and optical switches that help carry information using light. The proposed acquisition would give Marvell more of the technology needed to move data between increasingly powerful AI processors.
That is becoming a more demanding job. Adding computing power also increases the volume of information that must travel between chips and systems, putting pressure on bandwidth and electricity consumption. Marvell argues that designing electrical and optical components together will make it easier to meet those demands and bring products to market faster.
Lumentum’s growth helps explain the attraction. Revenue in its first fiscal quarter of 2027 reached $1.263 billion, up 136.5% from a year earlier. Its adjusted operating margin rose to 42.3%, while its operating margin under standard accounting rules was 28.5%.
The company also disclosed a second major win in near-packaged and co-packaged optics, backed by more than $5 billion in purchase commitments. These technologies bring optical connections closer to computing chips. The commitments give investors a reason to watch the production ramp, though they have yet to become recognized revenue.
For its second fiscal quarter, Lumentum forecast revenue of $1.575 billion to $1.625 billion and adjusted earnings of $5.90 to $6.20 a share. Meeting that outlook would demonstrate continued demand while the companies begin a lengthy merger process.
What the offer means for Lumentum shareholders
The agreement fixes the number of Marvell shares offered, leaving their dollar value to move with the market. A holder of 100 Lumentum common shares would receive 450 Marvell shares at closing. Existing Marvell shareholders would own approximately 67% of the combined company and Lumentum shareholders about 33%, on a fully diluted basis.
| Announced term | Detail |
|---|---|
| Exchange ratio | 4.5 Marvell common shares for each Lumentum common share |
| Implied enterprise value | $115 billion at the announcement’s reference prices |
| Reference premium | Approximately 23.9%, based on October 28 prices |
| Expected closing | First half of 2028, subject to conditions |
Lumentum closed November 2 at $684.40. The $771.35 value of the offer at Marvell’s closing price left a gap of approximately $86.95, or 12.70% of Lumentum’s share price. That gap reflects a transaction whose value and completion remain uncertain; it is not a return investors can lock in simply by buying Lumentum.
The effect of a changing Marvell price is straightforward:
| Hypothetical Marvell price at closing | Offer value per Lumentum share |
|---|---|
| $150 | $675 |
| $175 | $787.50 |
| $200 | $900 |
| $250 | $1,125 |
These figures illustrate the exchange ratio, rather than predict either stock’s price. Lumentum holders face Marvell’s market risk as well as the possibility of a delayed or failed transaction. If the deal closes, their investment becomes an interest in the combined business.
The return Marvell has to deliver
Marvell expects the combination to generate more than $1 billion in annual cost savings and to increase adjusted earnings per share in the first year after closing. Management also describes a $550 billion addressable market for the combined company. That estimate describes the opportunity it wants to pursue, rather than revenue it has secured.
Paying with shares spreads ownership across a larger shareholder base. The financial test is whether Lumentum’s earnings and the eventual savings outweigh the additional shares and integration costs. A smaller percentage ownership can still produce more earnings per share, but only if the acquired business delivers enough profit.
There is also a commercial test. Marvell wants customers to buy more of their connectivity technology from the combined company. It must do that while maintaining relationships with businesses that may also compete with parts of Lumentum’s portfolio.
Analysts question the timing and price
On the merger call, Bank of America’s Vivek Arya asked whether Marvell was buying Lumentum near the peak of a shortage in optical components. Barclays’ Tom O’Malley pressed management on the sources of cost savings and how long favorable supply-demand conditions might last. Those questions address a central risk: the market in 2028 may look different from the one supporting today’s valuation.
Marvell’s response was that the acquisition rests on a longer-term transition to optical connectivity. Management argued that demand for more integrated systems, rather than temporary scarcity alone, justified acting now. Investors will have several quarters of operating results to judge that argument before the expected closing.
NVIDIA had already committed capital to Lumentum. In March, it announced a $2 billion investment alongside a nonexclusive agreement covering advanced laser components and future capacity. That earlier agreement supports the importance of Lumentum’s technology, but it should not be presented as NVIDIA endorsing this merger. No new public endorsement from Jensen Huang or a competing chipmaker was verified in the sources reviewed for this article.
The November 2 analyst snapshot records Bank of America moving Marvell to Hold. It also lists a $370 target from Stifel and a $400 target from Piper Sandler, both dated October 29. Those targets predate the signed-deal announcement and should be read in that context.
Valuation after the selloff
Both stocks had already come under pressure during the takeover-speculation period. Marvell closed at $251.65 on October 28, then declined on October 29 and 30 before Monday’s further fall. The announcement therefore arrived after a substantial change in the value of the shares being offered.
| Stock | October 30 close | November 2 close | November 2 change |
|---|---|---|---|
| Marvell (MRVL) | $196.40 | $171.41 | −12.72% |
| Lumentum (LITE) | $840.70 | $684.40 | −18.59% |
The declines show a poor initial reception, although they cannot be attributed entirely to the deal. Technology stocks were also under pressure, and Lumentum released earnings that morning. Dilution concerns, valuation and merger-related trading may all have contributed.
At November 2 prices, a public market-data snapshot put Marvell’s common-equity value at approximately $150.3 billion and Lumentum’s at $62.0 billion. These are standalone market capitalizations, distinct from the transaction’s announced enterprise value. Comparing them with trailing revenue gives a sense of how much growth remains embedded in the stocks.
| Measure | Marvell | Lumentum |
|---|---|---|
| Approximate common-equity value | $150.3B | $62.0B |
| Trailing revenue | $9.45B | $3.74B |
| Calculated price-to-sales ratio | 15.9× | 16.6× |
The ratios use rounded figures and do not adjust for debt, cash or preferred securities. Even after the selloff, both valuations depend on substantial future growth.
How stock expectations could change
For Marvell, the checked analyst dataset lists adjusted earnings estimates of $4.22 a share for fiscal 2027 and $7.36 for fiscal 2028. At the November 2 close, the stock traded at approximately 40.6 times the first estimate and 23.3 times the second. The apparent fall in valuation depends on that forecast earnings increase being achieved; these estimates are not a verified forecast for the combined company.
The same November 2 snapshot includes 44 analysts, with an average one-year Marvell target of $337.36 and a range of $229.95 to $450. The average sits about 96.8% above the closing price. However, the aggregate mixes research dates and does not represent a fully updated view of the merger.
The next revisions will be more informative. Analysts need to account for the additional shares, integration spending, customer response and the timing of savings. Earnings forecasts could rise while the valuation investors are willing to pay falls, limiting the benefit to the stock price.
For Lumentum investors, standalone targets are becoming less useful as a guide to the eventual payout. Under the agreed terms, that payout depends on Marvell’s share price. Any assessment of Lumentum now needs to consider both businesses and the chance of completion.
The approvals still ahead
The filing lists both companies’ shareholder approvals, the U.S. Hart–Scott–Rodino antitrust waiting-period requirement, other required regulatory approvals and effectiveness of the SEC registration statement among the conditions for closing. These are substantive steps between signing and completion. The expected first-half 2028 closing date leaves a long period in which operating conditions and share prices can change.
A potential competition question is whether customers and rivals would retain access to important optical inputs on competitive terms. That is an analytical concern, not an allegation already made by a regulator against this transaction. The reviewed sources do not establish a complete jurisdiction-by-jurisdiction clearance list or a specific challenge by U.S., European or Chinese authorities.
The agreement provides for a $3.2 billion payment by Marvell if the deal terminates under specified regulatory conditions. It does not apply to every failed closing. The initial November 1, 2027 outside date can also extend under specified circumstances into 2028, so it should be read alongside those provisions rather than as an unconditional deadline.
What investors can assess before closing
The S-4 registration statement and joint proxy should provide more detail about the consideration, share counts, forecasts and the boards’ reasons for supporting the deal. Regulatory filings will establish the actual review milestones. Updated analyst models should also make it easier to distinguish views on the signed agreement from targets set before it was announced.
The companies still have businesses to run during that process. Lumentum needs to turn optical demand and purchase commitments into shipments and cash flow. Marvell must sustain its own growth while preparing to integrate a large acquisition.
For Lumentum holders, the immediate reference point is 4.5 times Marvell’s share price, adjusted for the risks and time remaining before closing. For Marvell holders, the longer-term question is whether the enlarged business can earn more per share after the cost of combining it. The deal gives Marvell a broader position in AI connectivity; its operating results will determine what that position is worth.
Primary Sources
- Marvell: acquisition announcement and strategic rationale
- Marvell SEC filing: exchange terms, closing conditions and termination provisions
- Lumentum: fiscal Q1 2027 results and Q2 guidance
- NVIDIA: March 2026 Lumentum investment and optics partnership
- Marvell: filed November 2 merger-call transcript
- FTC: premerger notification and merger review
FAQ
Has Marvell completed its acquisition of Lumentum?
No. The companies announced a definitive agreement on November 2, 2026. Closing is expected in the first half of 2028, subject to approvals and other conditions.
Do Lumentum shareholders receive $1,132 in cash?
No. The agreement provides 4.5 Marvell common shares per Lumentum common share. Approximately $1,132 was a reference value using October 28 prices, not a guaranteed cash payout.
Why does Marvell want Lumentum?
Marvell wants to combine its electrical connectivity and semiconductor products with Lumentum’s optical technologies as AI systems require more bandwidth and efficient data movement.
Does the merger guarantee higher Marvell earnings or stock prices?
No. Management expects adjusted EPS accretion after closing, but that is a forecast. Integration, demand, valuation and the new share count all affect the outcome.
What approvals does the transaction need?
The disclosed conditions include both shareholder votes, U.S. antitrust waiting-period requirements, other required regulatory approvals and effectiveness of the SEC registration statement. Completion is not assured.
